Providing Quality HIV Care

The Latest

This Week in HIV Research: How Low (an Atripla Dose) Can You Go?

Atripla may be just as effective when taken every other day; poor antiretroviral prescription fill rates after hospitalization; U.S. progress against UNAIDS targets; hepatitis C transmission clustering in France.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Rethinking PrEP Guidelines

Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Power of 10,000 Steps

Cardiorespiratory fitness and inflammation among sedentary people with HIV; helping patients increase physical activity; transwomen and metabolic syndrome; failed treatment of precancerous cervical lesions.

By Barbara Jungwirth and Myles Helfand

For Our Stable HIV Patients, Why Are We Still Sending All These Lab Tests So Often?

Do the guidelines for laboratory monitoring still make sense when our HIV treatments have become so safe and effective? Paul E. Sax, M.D., offers a revised -- and deliberately provocative -- recommendation.

By Paul E. Sax, M.D. for NEJM Journal Watch

This Week in HIV Research: Damming the Cascade of Unmet Needs

Unmet subsistence needs and clinical outcomes; finding HIV treatment success alongside quality-of-life issues; the potential value of facility-level HIV care continuum data; stimulant use and viral suppression.

By Barbara Jungwirth and Myles Helfand

Ketogenic Diet May Hold Promise for Older People With HIV

New scientific evidence suggests that the celebrity-backed diet may have significant cognitive benefits for older people living with HIV.

By Sony Salzman

This Week in HIV Research: Transgender Women in the Spotlight

Black transgender women and the HIV care continuum; PrEP uptake potential among trans women; an update on U.S. mother-to-child HIV transmission; is extra measles vaccination necessary?

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Getting Smart(Phone) About HIV Detection

A cellphone attachment that detects HIV RNA; HIV-2 does indeed often progress to AIDS; CD4 count declines and incident hepatitis C coinfection; the global demographics of non-Hodgkin lymphoma.

By Barbara Jungwirth and Myles Helfand

Why HIV Care Providers Should Discuss Marijuana Use With Their Patients

What are the benefits and risks of marijuana use for people living with HIV? The answer is complicated, and explains why clinician-patient communication on the issue is increasingly important.

By Sony Salzman

This Week in HIV Research: How Should We Measure Success?

The case for a new measurement of HIV treatment success; PrEP and HIV incidence in Australia; benefits of moderate exercise among older people with HIV; CD4 recovery rates after long-term viral suppression.

By Barbara Jungwirth and Myles Helfand